Prot# CTCH346A2211: A Rndmzd, Dbl-Blnd, Placebo-Cntrlld, Stratified, Parallel-Group, Multicenter, Dose-Ranging Study Evaluating 4 Oral Doses of TCH346(1.0, 2.5, 7.5 & 15 mg)Administered 1x Daily in Patients w/Amyotrophic Lateral Sclerosis
- Sufit, Robert L (PD/PI)
- Siddique, Teepu (Co-PD/PI)
Project: Research project